NEVRO (NVRO, $10.41) was a top loser over the last three months, falling -3 to $10.41 per share. A.I.dvisor analyzed 460 stocks in the Medical Specialties Industry for the 3-month period ending May 1, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend. 451 similar cases when NVRO's price dropped within three months. In out of those 451 cases, NVRO's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for NVRO are